ArticleOcular oncology and pathology2026

Drug Rechallenge after Immune Checkpoint Inhibitor-Induced Inflammation and Optic Nerve Disorders.

Julia Canestraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.